Primary contact

Founded in 2013, Macro-Eyes is a machine learning company that simplifies personalized care. The company's offering includes Pymed, a software for clinical decision support, which identifies patients that are multi-dimensionally similar to the patient being provided care and clinical events that are similar to the event that requires a response; and Sibyl, a predictive scheduling application that cuts revenue loss due to no-shows and increases utilization. It's a seamless add-on to your scheduling system. Macro-Eyes is also developing a product for the supply chain of the future to help patients and clinicians determine the device and the associated care bundle that leads to optimal outcomes for specific sets of patients. The structure and scope of Macro-Eyes AI is informed by years of initial work with clinicians, data-scientists and administrators at health systems and leading academic medical centers in New York City and California.
Primary contact

Funding 💰

Total $100K
Select investors Dreamit Health, Bill & Melinda Gates Foundation
Last update: May 9, 2018